Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
  1. 8-K Event Other events
  2. 4 Planned sale CHIEF FINANCIAL OFFICER sold 573 shares at an average $18.51 ($10,608)
  3. 4 Planned sale CHIEF FINANCIAL OFFICER sold 470 shares at $17.31 ($8,136)
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 4 Planned sale CHIEF MEDICAL OFFICER sold 815 shares at $14.65 ($11,940)
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 4 Grant or award Director acquired 6,500 shares (grant or award)
  12. 4 Grant or award Director acquired 6,500 shares (grant or award)
  13. 4 Grant or award Director acquired 6,500 shares (grant or award)
  14. 4 Grant or award Director acquired 6,500 shares (grant or award)
  15. 4 Grant or award Director acquired 6,500 shares (grant or award)
  16. 4 Grant or award Director acquired 6,500 shares (grant or award)
  17. 4 Grant or award Director acquired 6,500 shares (grant or award)
  18. 4 Grant or award Director acquired 6,500 shares (grant or award)
  19. 4 Grant or award Director acquired 6,500 shares (grant or award)
  20. 8-K Event Executive or director change · Shareholder vote results

Page 11 of 65 · 1,286 filings